This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Universidad Complutense De Madrid. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Javier Regidor Cerrillo: Innovator in Vaccine Composition
Introduction
Javier Regidor Cerrillo is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of vaccine development, particularly through his innovative protein compositions. His work aims to enhance the treatment of infections, showcasing his commitment to advancing medical science.
Latest Patents
Javier holds a patent for a vaccine composition that relates to new protein compositions and methods for producing these compositions. The patent details pharmaceutical compositions that include these proteins and methods for treating infections caused by them. Specifically, the invention involves a protein composition that contains specified proteins in an amount at least about two times higher than the same protein present in the whole tachyzoite, as determined by quantitative label-free liquid chromatography-tandem mass spectrometry (LC-MS/MS). This innovative approach has the potential to improve vaccine efficacy.
Career Highlights
Throughout his career, Javier has worked with prestigious institutions, including Universidad Complutense de Madrid and Laboratorios Hipra, S.A. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Javier has collaborated with notable colleagues such as David Arranz Solís and Esther Collantes Fernández. These partnerships have enriched his research and expanded the impact of his work in vaccine development.
Conclusion
Javier Regidor Cerrillo is a distinguished inventor whose work in vaccine composition is paving the way for advancements in medical treatments. His innovative approaches and collaborations highlight his dedication to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
